Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional Multi-Center Post Market Randomized Controlled Open-Label Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Hard to Heal Diabetic Foot Wounds

NCT04537520 is registered in ClinicalTrials.gov with Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète as lead sponsor.

NCT NCT04537520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04537520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional Multi-Center Post Market Randomized Controlled Open-Label Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Hard to Heal Diabetic Foot Wounds
Lead sponsor
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Phase
Not applicable
Overall status
Completed
Start date
July 2, 2020
Completion date
December 16, 2022
Enrollment
180 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetic foot ulcer